Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan B King

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the American Heart Association|December 5, 2018
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up DataMihail G Chelu, Jordan B King, Eugene G Kholmovski, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study ProtocolHeeseung Hong, Aaron S Wilson, Aubrey E Jones, et al.
Journal of Clinical Lipidology|August 28, 2021
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarctionCalvin L Colvin, Bharat Poudel, Adam P Bress, et al.
JAMA Cardiology|October 28, 2020
Estimated Prevalence of Masked Asleep Hypertension in US AdultsSiling Li, Joseph E Schwartz, Daichi Shimbo, et al.
Journal of the American Heart Association|October 6, 2021
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection FractionApril F Mohanty, Emily B Levitan, Jordan B King, et al.
Journal of the American Heart Association|April 6, 2021
Factors Associated With PCSK9 Inhibitor Initiation Among US VeteransCatherine G Derington, Lisandro D Colantonio, Jennifer S Herrick, et al.
American Journal of Hypertension|January 18, 2022
Predicting Out-of-Office Blood Pressure in a Diverse US PopulationBrandon K Bellows, Jingyu Xu, James P Sheppard, et al.
JAMA Network Open|January 28, 2022
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive ImpairmentZachary A Marcum, Jordana B Cohen, Chong Zhang, et al.
JAMA Network Open|May 19, 2023
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical TrialLama Ghazi, Jincheng Shen, Jian Ying, et al.
Journal of the American Heart Association|May 6, 2021
Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort DataBrandon K Bellows, Yiyi Zhang, Zugui Zhang, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the American Heart Association|December 5, 2018
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up DataMihail G Chelu, Jordan B King, Eugene G Kholmovski, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study ProtocolHeeseung Hong, Aaron S Wilson, Aubrey E Jones, et al.
Journal of Clinical Lipidology|August 28, 2021
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarctionCalvin L Colvin, Bharat Poudel, Adam P Bress, et al.
JAMA Cardiology|October 28, 2020
Estimated Prevalence of Masked Asleep Hypertension in US AdultsSiling Li, Joseph E Schwartz, Daichi Shimbo, et al.
Journal of the American Heart Association|October 6, 2021
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection FractionApril F Mohanty, Emily B Levitan, Jordan B King, et al.
Journal of the American Heart Association|April 6, 2021
Factors Associated With PCSK9 Inhibitor Initiation Among US VeteransCatherine G Derington, Lisandro D Colantonio, Jennifer S Herrick, et al.
American Journal of Hypertension|January 18, 2022
Predicting Out-of-Office Blood Pressure in a Diverse US PopulationBrandon K Bellows, Jingyu Xu, James P Sheppard, et al.
JAMA Network Open|January 28, 2022
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive ImpairmentZachary A Marcum, Jordana B Cohen, Chong Zhang, et al.
JAMA Network Open|May 19, 2023
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical TrialLama Ghazi, Jincheng Shen, Jian Ying, et al.
Journal of the American Heart Association|May 6, 2021
Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort DataBrandon K Bellows, Yiyi Zhang, Zugui Zhang, et al.
Pageof 7